Illumina fined record €432m for completing Grail merger before EC approval
Commission says dealmakers ‘knowingly and intentionally’ breached standstill obligation | Grail receives the first-ever fine for a target company under EU merger rules.
Medtronic faces patent review revival as Fed Cir faults PTAB
Precedential decision marks blow for medical device maker after earlier win | PTAB criticised for “fundamental legal error” and “narrow definition”.
Novartis vows to challenge heart drug patent loss
Decision affects a patent listed in the Orange Book | Generic drug makers have so far failed to secure approval for biosimilar versions of the blockbuster drug.
Dechert hires Harvard-educated chemist as IP partner
John Rearick is the latest addition to the firm to strengthen its life sciences practice.
FTC wades into Medtronic bipolar energy case
Commission says that medical device maker’s arguments have broad implications for antitrust enforcement | Dispute concerns alleged exclusive-dealing and bundling arrangements.
Morgan Lewis opens office in China
The firm’s presence in Shenzhen will expand its focus on tech industries in the region.
Lewis Silkin acquires tech and life sciences firm
Lewis Silkin has integrated MSK into its practice to better manage complex portfolios across various tech sectors.
US appeals court upholds decision on wrinkle treatment
Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’.
UPC: Milan confirmed as third seat but Munich lands chemistry, minus SEPs
UPC Administrative Committee 'voted unanimously' to approve Milan says Italian politician | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs.
UK appoints first female Lord Chief Justice in 755 years
Dame Sue Carr takes over from Lord Burnett of Maldon, assuming responsibilities in October.
